by The Vitreous Tamponades Market is estimated to be valued at US$ 83.89 Mn in 2023 and is expected to exhibit a CAGR of 2.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Vitreous tamponades are intraocular materials, usually gases or silicone oils, which are often used in retinal detachment surgery. They are inserted in the interior of the eyeball temporarily to flatten the retina against the choroid by applying pressure on the retina. The most commonly used vitreous tamponades are silicone oils and gases like sulfur hexafluoride, perfluoroethane or perfluoropropane.
Market Dynamics:
The increasing prevalence of retinal detachment is primarily driving the growth of the market. For instance, according to a study published by the US National Library of Medicine, it is estimated that the annual incidence and lifetime risk of retinal detachment is around 1 in 10,000 and 1 in 300 respectively in the United States.
Secondly, the rising demand for biodegradable and biosynthetic vitreous tamponades is creating potential growth opportunities in the market. The need for sustainable materials is encouraging key manufacturers to focus on developing novel biodegradable tamponades which will dissolve naturally in the vitreous cavity over time and reduce the need for secondary removal surgeries.
Segment Analysis
The vitreous tamponades market is segmented into gas tamponades, silicone oil tamponades, and perfluorocarbon liquids. Among these, silicone oil tamponades dominate the market owing to their higher safety profile and biocompatibility as compared to other segments. Silicone oil is preferred as vitreous tamponade during vitreoretinal surgeries due to its ability to remain immiscible with soft tissue, prevents dispersion while also maintaining good tamponading properties.
PEST Analysis
Political: The government regulations related to the approval of new tamponade agents and medical devices in various countries impacts the market positively or negatively.
Economic: Increasing geriatric population and rising incidences of retinal detachment and macular hole disease are driving the market growth. However, high costs associated may hamper the market.
Social: Growing awareness about ocular diseases and their surgical treatments support the market growth. Additionally, rising healthcare expenditure furthers boosts the demand.
Technological: Advancements in vitrectomy systems, new tamponade delivery techniques, and emergence of biodegradable tamponades are expected to provide growth opportunities in the forecast period.
Key Takeaways
The global vitreous tamponades market is expected to witness high growth, exhibiting CAGR of 2.5% over the forecast period, due to increasing prevalence of retinal detachment and diabetic retinopathy. The market size for 2023 is estimated to be US$ 83.89 Mn.
Regionally, North America dominated the vitreous tamponades market in 2020 owing to rapid adoption of advanced vitreoretinal surgical techniques in the region. Rising prevalence of ocular diseases with growing geriatric population also supplements the regional market growth.
Key players operating in the vitreous tamponades market are Alchimia srl, Alcon, Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG, Croma-Pharma GmbH, Dutch Ophthalmic Research Center (International) B.V., and Fluoron GmbH. Silicone oils produced by key players like Bausch Health and Alcon accounted for over 60% share of the global market in 2020.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
